Research Paper Volume 12, Issue 14 pp 14918—14932

RP11-295G20.2 facilitates hepatocellular carcinoma progression via the miR-6884-3p/CCNB1 pathway

class="figure-viewer-img"

Figure 1. RP11-295G20.2 is highly expressed in HCC tissues and cell lines. (A) The expression profile of RP11-295G20.2 in various cancers by analysing TCGA database using GEPIA. (B) The expression level of RP11-295G20.2 in HCC by analysing GEPIA, *P < 0.05. (C) RT-qPCR results of RP11-295G20.2 expression in HCC tissues (n=30) and paracancerous tissues(n=30), *P < 0.05. (D) RP11-295G20.2 expression in HCC cell lines was detected using RT-qPCR, *P < 0.05. (E) Kaplan-Meier analysis of the correlation between RP11-295G20.2 expression and overall survival (OS) in patients with HCC using GEPIA.